Study of FotonaSmooth ErbiumYAG Laser Treatment for Urethral Pain Syndrome in Adult Women

What this Trial Is About

Pelvic Pain Syndrome, specifically Urethral Pain Syndrome UPS, involves persistent or recurring urethral pain without infection or clear cause. This study aims to evaluate the effects of intraurethral and vaginal laser therapy on reducing urethral pressure pain in women with UPS. The research explores a new treatment option because existing therapies often show limited improvement, and laser therapy has shown promise in related gynecological conditions. Participants will receive intraurethral and vaginal laser treatment using the FotonaSmooth ErbiumYAG laser. This is a single-center, prospective pilot study designed to assess the safety and effectiveness of this laser therapy for UPS. The treatment process involves laser application directly to the urethral and vaginal areas, aiming to relieve symptoms and reduce pain. During the study, women will be monitored over several months with assessments including symptom improvement, reduction in tissue induration, pain levels during treatment, infection status, and satisfaction with treatment outcomes. These evaluations will occur at 3, 5, and 12 months after treatment. Participants will complete questionnaires and undergo clinical examinations to track progress and safety, with the total follow-up period extending up to 12 months.

FotonaSmooth Erbium:YAG Laser for the Treatment of Urethral Pain Syndrome in Women